OncoCell MDx raises $22.2m for liquid biopsy immunogenomics platform
OncoCell MDx, a Michigan-based immugenomics platform company, which is focused on developing noninvasive blood-based diagnostic tests, has secured $22.2 million in a Series B financing round. Savitr Capital led the funding round, which also saw participation from the existing investors of OncoCell MDx. Andrew Midler – Managing Member at Savitr said: “OncoCell is harnessing the […]